1 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Microvascular Inflammation: new trials by email Literature Review of Microvascular Inflammation trials Research Report on Microvascular Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE) Felzartamab - Antibody-mediated Rejection, Microvascular Inflammation | Phase 3 | Enrolling by invitation | Biogen | 201 | 2026-04-16 | 2026-10-09 |
| A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation Felzartamab, Placebo - Microvascular Inflammation | Phase 2 | Recruiting | Biogen | 81 | 2026-01-05 | 2026-10-23 |
| Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation Blood draw, Urine draw - Kidney Transplantation, Kidney Allograft Biopsy | Not yet recruiting | University Hospital, Strasbourg, France | 570 | 2023-06-01 | 2023-06-08 |
felzartamab (2) · Blood Specimen Collection (1)
Biogen (2) · University Hospital, Strasbourg, France (1)
United States (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Spain (1) · Switzerland (1)
2025 (1)